
Adagene ADAG
€ 3.10
-1.37%
Geschäftsbericht 2025
hinzugefügt 25.04.2026
Adagene Abschreibung & Amortisation 2011-2026 | ADAG
Abschreibung & Amortisation Jährlich Adagene
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 439 K | 723 K | 980 K | 1.15 M | 1.13 M | 858 K | 817 K | 909 K | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.15 M | 439 K | 875 K |
Abschreibung & Amortisation anderer Aktien in der Pharmaeinzelhändler
| Name | Abschreibung & Amortisation | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Happiness Biotech Group Limited
HAPP
|
380 K | - | 1.35 % | $ 17.8 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
31.6 M | $ 16.88 | -2.43 % | $ 789 M | ||
|
AgeX Therapeutics
AGE
|
100 K | - | -10.17 % | $ 12.2 K | ||
|
Compugen Ltd.
CGEN
|
461 K | $ 2.79 | -8.09 % | $ 261 M | ||
|
Coherus BioSciences
CHRS
|
1.3 M | $ 1.6 | -2.15 % | $ 187 M | ||
|
I-Mab
IMAB
|
23.9 M | - | - | $ 866 M | ||
|
AstraZeneca PLC
AZN
|
5.73 B | - | - | $ 96.9 B | ||
|
Arcturus Therapeutics Holdings
ARCT
|
3.02 M | $ 7.56 | -3.45 % | $ 207 M | ||
|
Athira Pharma
ATHA
|
972 K | - | - | $ 269 M | ||
|
Galera Therapeutics
GRTX
|
20 K | - | -32.59 % | $ 7.61 M | ||
|
Esperion Therapeutics
ESPR
|
105 K | $ 3.13 | 0.32 % | $ 651 M | ||
|
Exelixis
EXEL
|
29.1 M | $ 50.41 | -1.36 % | $ 13.7 B | ||
|
Fortress Biotech
FBIO
|
403 K | $ 2.43 | 5.65 % | $ 67.8 M | ||
|
Forte Biosciences
FBRX
|
64 K | $ 23.1 | -3.57 % | $ 299 M | ||
|
AbCellera Biologics
ABCL
|
18.4 M | $ 4.09 | -7.05 % | $ 1.22 B | ||
|
Autolus Therapeutics plc
AUTL
|
8.3 M | $ 1.59 | - | $ 423 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
66 K | - | - | $ 231 M | ||
|
Galectin Therapeutics
GALT
|
1 K | $ 2.22 | -5.74 % | $ 142 M | ||
|
Gilead Sciences
GILD
|
370 M | $ 130.07 | -1.51 % | $ 162 B | ||
|
Advaxis
ADXS
|
369 K | - | -9.65 % | $ 45.9 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
24 K | $ 3.41 | -2.25 % | $ 5.61 M | ||
|
Aeterna Zentaris
AEZS
|
58 K | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.51 M | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
105 K | - | 1.93 % | $ 17.4 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
546 K | $ 0.72 | -1.05 % | $ 32.9 M | ||
|
Akero Therapeutics
AKRO
|
18 K | - | - | $ 3.67 B | ||
|
Eton Pharmaceuticals
ETON
|
4.04 M | $ 29.69 | -0.92 % | $ 799 M | ||
|
Aptose Biosciences
APTO
|
22 K | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
122 K | - | -39.0 % | $ 4.57 M | ||
|
Akouos
AKUS
|
2.49 M | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
274 K | - | -0.23 % | $ 916 M | ||
|
AlloVir
ALVR
|
13 K | - | 4.14 % | $ 49.1 M | ||
|
Allakos
ALLK
|
6.14 M | - | - | $ 28.6 M | ||
|
Arcutis Biotherapeutics
ARQT
|
700 K | $ 21.51 | -0.3 % | $ 2.74 B | ||
|
Allena Pharmaceuticals
ALNA
|
363 K | - | 3.16 % | $ 1.9 M |